SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001052918-21-000223
Filing Date
2021-06-23
Accepted
2021-06-22 21:20:13
Documents
7
Period of Report
2020-08-31

Document Format Files

Seq Description Document Type Size
1 AVRICORE HEALTH INC. avricore6kaugust2020.htm 6-K 10176
2 EXHIBIT 99.1 financials_ex99z1.htm EX-99.1 264576
3 EXHIBIT 99.2 mda_ex99z2.htm EX-99.2 114022
4 EXHIBIT 99.3 ceocert_ex99z3.htm EX-99.3 6173
5 EXHIBIT 99.4 cfocert_ex99z4.htm EX-99.4 6144
6 IMAGE financialsex99z1_1.jpg GRAPHIC 7378
7 IMAGE mdaex99z2_1.jpg GRAPHIC 7378
  Complete submission text file 0001052918-21-000223.txt   423048
Mailing Address 789 WEST PENDER STREET SUITE 810 VANCOUVER A1 V6C 1H2
Business Address 789 WEST PENDER STREET SUITE 810 VANCOUVER A1 V6C 1H2 604-687-2038
Avricore Health Inc. (Filer) CIK: 0001355736 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-51848 | Film No.: 211037056
SIC: 2834 Pharmaceutical Preparations